Trial Profile
A Study to Evaluate the Safety of Rituximab Multiple Retreatments in Patients with Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Acronyms AIR
- 10 Dec 2015 New trial record